Implementing national guidelines on risk prediction and primary prevention of coronary heart disease in a cardiology information system von Becht, A.A., van der Velde, E.T., Atsma, D.E., Hoekstra, W.H.G.J., van Dieren, E.B., Jonker, L.L.

Volltext

The prevalence of mental health problems in sub-Saharan adolescents living with HIV: a systematic review von Dessauvagie, A.S., Jörns-Presentati, A., Napp, A.-K., Stein, D.J., Jonker, D., Breet, E., Charles, W., Swart, R. L., Lahti, M., Suliman, S., Jansen, R., van den Heuvel, L.L., Seedat, S., Groen, G.

Volltext

1758PD - Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG) von Wells, J.C., Sidhu, A., Ding, K., Heng, D.Y.C., Shepherd, F., Ellis, P.M., Bradbury, P.A., Jonker, D.J., Moore, M., Siu, L.L., Gelmon, K.A., Karapetis, C., Shapiro, J., Nott, L., O’Callaghan, C.J., Parulekar, W.R., Seymour, L.K., Smoragiewicz, M., Monzon, J.G.

Volltext

Association between transit-amplifying signature and outcomes of patients treated with anti-epidermal growth factor receptor (EGFR) therapy in colorectal cancer von Fontana, E., Nyamundanda, G., Cunningham, D., Jonker, D.J., Siu, L.L., Tu, D., Sclafani, F., Eason, K.V., Ragulan, C., Hulkki-Wilson, S., Loree, J.M., Giordano, M., Lawrence, P.V., Shapiro, J., Cremolini, C., Starling, N., Pietrantonio, F., Trusolino, L., O’Callaghan, C., Sadanandam, A.

Volltext

530PD - Association between transit-amplifying signature and outcomes of patients treated with anti-epidermal growth factor receptor (EGFR) therapy in colorectal cancer von Fontana, E., Nyamundanda, G., Cunningham, D., Jonker, D.J., Siu, L.L., Tu, D., Sclafani, F., Eason, K.V., Ragulan, C., Hulkki-Wilson, S., Loree, J.M., Giordano, M., Lawrence, P.V., Shapiro, J., Cremolini, C., Starling, N., Pietrantonio, F., Trusolino, L., O’Callaghan, C., Sadanandam, A.

Volltext

Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG) von Wells, J.C., Sidhu, A., Ding, K., Heng, D.Y.C., Shepherd, F., Ellis, P.M., Bradbury, P.A., Jonker, D.J., Moore, M., Siu, L.L., Gelmon, K.A., Karapetis, C., Shapiro, J., Nott, L., O’Callaghan, C.J., Parulekar, W.R., Seymour, L.K., Smoragiewicz, M., Monzon, J.G.

Volltext

Is the derived neutrophil to lymphocyte ratio (dNLR) an independent prognostic marker in patients with metastatic colorectal cancer (mCRC)? Analysis of the CO.17 and CO.20 studies von Diakos, C.I., Tu, D., Gebski, V., Yip, S., Wilson, K., Karapetis, C.S., O'Callaghan, C.J., Shapiro, J., Tebbutt, N., Jonker, D.J., Siu, L.L., Wong, R., Doyle, C., Strickland, A.H., Price, T.J., Simes, J., Clarke, S.

Volltext

29 A First-in-Human Phase I Monotherapy Study of RG7212 (R), a Novel Monoclonal Antibody Targeting TWEAK Signaling in Patients with Advanced Solid Tumors von Lassen, U, Schellens, J.H.M, Siu, L.L, Jonker, D.J, Sorensen, M, Jarutat, T, Wang, K, Geho, D, DeMario, M, Goss, G

Volltext

470PA PHASE I STUDY OF ERIBULIN AND GEMCITABINE IN PATIENTS WITH AVANCED SOLID TUMOURS. A STUDY OF THE PRINCESS MARGARET PHASE II CONSORTIUM von Goel, R., Lheureux, S., Laurie, S.A., Halford, R.A., Jonker, D., Chen, E.X., Keller, D., Bourada, V., Wang, L., Doyle, L.A., Siu, L.L., Oza, A.M.

Volltext

A Phase I Study of Eribulin and Gemcitabine in Patients with Avanced Solid Tumours. a Study of the Princess Margaret Phase Ii Consortium von Goel, R., Lheureux, S., Laurie, S.A., Halford, R.A., Jonker, D., Chen, E.X., Keller, D., Bourada, V., Wang, L., Doyle, L.A., Siu, L.L., Oza, A.M.

Volltext